134 related articles for article (PubMed ID: 35795372)
1. Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease.
Li B; Zamzam A; Syed MH; Jahanpour N; Jain S; Abdin R; Qadura M
Front Cardiovasc Med; 2022; 9():875244. PubMed ID: 35795372
[TBL] [Abstract][Full Text] [Related]
2. Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease.
Li B; Zamzam A; Syed MH; Jahanpour N; Jain S; Abdin R; Qadura M
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883416
[TBL] [Abstract][Full Text] [Related]
3. Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease.
Zamzam A; Syed MH; Harlock J; Eikelboom J; Singh KK; Abdin R; Qadura M
Sci Rep; 2021 May; 11(1):11061. PubMed ID: 34040076
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein 4 has prognostic value in peripheral artery disease.
Li B; Zamzam A; Syed MH; Djahanpour N; Jain S; Abdin R; Qadura M
J Vasc Surg; 2023 Sep; 78(3):719-726. PubMed ID: 37318430
[TBL] [Abstract][Full Text] [Related]
5. The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events.
Li B; Djahanpour N; Zamzam A; Syed MH; Jain S; Arfan S; Abdin R; Qadura M
Front Cardiovasc Med; 2022; 9():1073751. PubMed ID: 36582735
[TBL] [Abstract][Full Text] [Related]
6. Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study.
Zamzam A; Syed MH; Rotstein OD; Eikelboom J; Klein DJ; Singh KK; Abdin R; Qadura M
EClinicalMedicine; 2023 Jan; 55():101766. PubMed ID: 36531981
[TBL] [Abstract][Full Text] [Related]
7. Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease.
Ehsan M; Syed MH; Zamzam A; Jahanpour N; Singh KK; Abdin R; Qadura M
Sci Rep; 2022 May; 12(1):8312. PubMed ID: 35585171
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data.
Li B; Nassereldine R; Zamzam A; Syed MH; Mamdani M; Al-Omran M; Abdin R; Qadura M
J Vasc Surg; 2024 Apr; ():. PubMed ID: 38599293
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis-related proteins as biomarkers for peripheral artery disease.
Li B; Djahanpour N; Zamzam A; Syed MH; Jain S; Abdin R; Qadura M
Heliyon; 2023 Sep; 9(9):e20166. PubMed ID: 37809892
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid binding protein 3 is associated with peripheral arterial disease.
Syed MH; Zamzam A; Khan H; Singh K; Forbes TL; Rotstein O; Abdin R; Eikelboom J; Qadura M
JVS Vasc Sci; 2020; 1():168-175. PubMed ID: 34617045
[TBL] [Abstract][Full Text] [Related]
11. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
12. Association of the Prognosis of Ankle-brachial Index Improvement One Year Following Endovascular Therapy in Patients with Peripheral Artery Disease: Data from the I-PAD NAGANO Registry.
Senda K; Miura T; Kato T; Kanzaki Y; Abe N; Yokota D; Yanagisawa T; Okina Y; Wakabayashi T; Oyama Y; Karube K; Itagaki T; Yoda H; Shoin K; Oguchi Y; Aizawa K; Suzuki C; Kuwahara K;
Intern Med; 2021 Jul; 60(13):1999-2006. PubMed ID: 33518563
[TBL] [Abstract][Full Text] [Related]
13. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.
Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Savvidis S; Messow CM; Munzel T; Blankenberg S;
Circulation; 2008 Aug; 118(9):961-7. PubMed ID: 18697822
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study.
Arfan S; Zamzam A; Syed MH; Jain S; Jahanpour N; Abdin R; Qadura M
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453628
[TBL] [Abstract][Full Text] [Related]
15. Urinary Biomarkers and Kidney Outcomes: Impact of Indexing Versus Adjusting for Urinary Creatinine.
Wettersten N; Katz R; Shlipak MG; Scherzer R; Waikar SS; Ix JH; Estrella MM
Kidney Med; 2021; 3(4):546-554.e1. PubMed ID: 34401722
[TBL] [Abstract][Full Text] [Related]
16. Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Hess CN; Debus ES; Nehler MR; Anand SS; Patel MR; Szarek M; Capell WH; Hsia J; Beckman JA; Brodmann M; Diaz R; Habertheuer P; Leeper NJ; Powell RJ; Sillesen H; Muehlhofer E; Berkowitz SD; Haskell LP; Bauersachs RM; Bonaca MP
Circulation; 2021 Dec; 144(23):1831-1841. PubMed ID: 34637332
[TBL] [Abstract][Full Text] [Related]
17. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting.
Aboyans V; Lacroix P; Postil A; Guilloux J; Rollé F; Cornu E; Laskar M
J Am Coll Cardiol; 2005 Sep; 46(5):815-20. PubMed ID: 16139130
[TBL] [Abstract][Full Text] [Related]
18. Effects of Three Different Methods Defining Onset of Peripheral Artery Disease on the Assessments of Incidence and Important Predictors - Results from the German Epidemiological Trial on Ankle Brachial Index (getABI).
Lupilov A; Krause D; Klaassen-Mielke R; Trampisch HJ; Rudolf H
Vasc Health Risk Manag; 2021; 17():421-429. PubMed ID: 34335027
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
